Artificial intelligence is transforming how we use real-world evidence (RWE) to improve patient care. As highlighted in Med Ad News’s online edition, pharmalive.com in the article, “AI backs up RWE”, machine learning is helping uncover patterns in vast healthcare datasets—accelerating diagnoses, personalizing treatments, and enhancing decision-making.
EVERSANA is at the forefront of this shift. From predictive modeling to AI-powered commercialization, our teams are applying these tools to deliver faster, more precise solutions.
Dr. Pierantonio Russo, EVERSANA’s Corporate Chief Medical Officer, explains:
“With the amount of data found in pharma and health care, using just the human approach to review these complex data sets means that some of the trends and nuances can be missed. Machine learning and other forms of AI can help, both in diagnostic as well as in prevention as well as in content generation.”
As regulators embrace RWE and global collaboration grows, EVERSANA remains committed to responsible innovation—keeping patients and providers at the center.
Read the full article on Med Ad News.
Connect With An Expert!
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…